Bai Guirong, Xie Xiaomin, Liu Huili, Qiang Dan, He Yanting, Zhang Li, Zhang Xiaojuan
Department of Endocrinology, The First People's Hospital of Yinchuan, Yinchuan, China.
Endokrynol Pol. 2023;74(3):271-276. doi: 10.5603/EP.a2023.0032. Epub 2023 May 8.
Complement C1q tumour necrosis factor-related protein (CTRP-1) is a member of the C1q protein superfamily that plays a role in metabolism. This retrospective study aimed to investigate associations between CTRP-1 and metabolic syndrome (MetS).
This study screened subjects who had undergone regular health examinations at the Physical Examination Centre in the First People's Hospital of Yinchuan (the Second Affiliated Hospital of Ningxia Medical University) between November 2017 and September 2020. The total recruited population included 430 subjects who had undergone regular health examinations, excluding 112 subjects with high glycated haemoglobin (HbA1c ≥ 7). Finally, the data of 318 participants were further analysed. Non-diabetic subjects were divided into 2 groups: one with MetS and one without MetS (controls). Serum CTRP-1 concentrations were evaluated using an enzyme-linked immunosorbent assay.
A total of 318 subjects were included, among whom 176 were diagnosed with MetS (MetS group) and 142 were not (non-MetS controls). The MetS group had significantly lower CTRP-1 levels than non-MetS controls (128.51 [111.56-143.05] vs. 138.82 [122.83-154.33] ng/mL, p < 0.001). Correlation analysis showed that serum CTRP-1 levels correlated negatively with body mass index (r = -0.161, p = 0.004), waist circumference (r = -0.191, p = 0.001), systolic blood pressure (r = -0.198, p < 0.001), diastolic blood pressure (r = -0.145, p = 0.010), fasting blood glucose (FBG) (r = -0.562, p < 0.001), fasting insulin (FIns) (r = -0.424, p < 0.001), and homeostasis model assessment of insulin resistance (HOMA-IR) (r = -0.541, p < 0.001). Multiple linear regression models showed that CTRP-1 levels were associated with MetS (p < 0.01). The lipid profile area under the curve (AUC) was comparable to those for FBG and FIns, and it was significantly higher than the AUCs for demographic variables.
The results of this study suggest that the serum CTRP-1 level is negatively associated with MetS. CTRP-1 is a potential metabolism-related protein and is likely to be associated with lipid profiles in MetS.
补体C1q肿瘤坏死因子相关蛋白(CTRP-1)是C1q蛋白超家族的成员,在新陈代谢中发挥作用。这项回顾性研究旨在调查CTRP-1与代谢综合征(MetS)之间的关联。
本研究筛选了2017年11月至2020年9月期间在银川市第一人民医院(宁夏医科大学第二附属医院)体检中心接受定期健康检查的受试者。招募的总人群包括430名接受定期健康检查的受试者,排除112名糖化血红蛋白高(HbA1c≥7)的受试者。最后,对318名参与者的数据进行了进一步分析。非糖尿病受试者分为两组:一组患有MetS,一组未患MetS(对照组)。使用酶联免疫吸附测定法评估血清CTRP-1浓度。
共纳入318名受试者,其中176名被诊断为MetS(MetS组),142名未患MetS(非MetS对照组)。MetS组的CTRP-1水平显著低于非MetS对照组(128.51[111.56 - 143.05]对138.82[122.83 - 154.33]ng/mL,p<0.001)。相关性分析表明,血清CTRP-1水平与体重指数呈负相关(r = -0.161,p = 0.004)、腰围(r = -0.191,p = 0.001)、收缩压(r = -0.198,p<0.001)、舒张压(r = -0.145,p = 0.010)、空腹血糖(FBG)(r = -0.562,p<0.001)、空腹胰岛素(FIns)(r = -0.424,p<0.001)以及胰岛素抵抗稳态模型评估(HOMA-IR)(r = -0.541,p<0.001)。多元线性回归模型显示CTRP-1水平与MetS相关(p<0.01)。曲线下脂质谱面积(AUC)与FBG和FIns的AUC相当,且显著高于人口统计学变量的AUC。
本研究结果表明血清CTRP-1水平与MetS呈负相关。CTRP-1是一种潜在的与代谢相关的蛋白,可能与MetS中的脂质谱相关。